Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	68.97	37.57	28.67	62.89	39.02	148.99
Short-Term Investments	100.7	108.13	18.57	45.96	133.54	-
Cash & Short-Term Investments	169.67	145.7	47.24	108.85	172.56	148.99
Cash Growth	4.35%	208.44%	-56.60%	-36.92%	15.82%	3244.31%
Receivables	-	-	5.9	5.49	1.86	-
Inventory	-	-	5.31	6.43	1.86	-
Prepaid Expenses	2.3	3.32	2.84	3.83	3.75	2.28
Total Current Assets	171.97	149.01	61.29	124.59	180.03	151.27
Property, Plant & Equipment	0.22	0	7.63	5.97	2.03	0.61
Other Intangible Assets	-	-	-	-	-	3.81
Other Long-Term Assets	1.5	1.81	1.4	1.87	2.18	2.21
Total Assets	173.69	150.83	70.32	132.42	184.24	157.91

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.22	0.92	2.16	5.9	3.52	6.44
Accrued Expenses	8.09	13.6	14.65	14.31	13.35	8.7
Current Portion of Leases	0.13	-	0.27	0.43	0.39	0.13
Other Current Liabilities	-	-	-	5.76	1.57	-
Total Current Liabilities	10.44	14.52	17.07	26.4	18.84	15.27
Long-Term Leases	0.09	-	0.57	0.83	1.27	0.47
Other Long-Term Liabilities	-	-	0.2	-	5.76	5.76
Total Liabilities	10.53	14.52	17.84	27.23	25.86	21.5

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	576.66	489.44	385.11	374.13	361.69	279.09
Retained Earnings	-413.29	-353.25	-332.65	-268.96	-203.2	-142.69
Comprehensive Income & Other	-0.22	0.12	0.02	0.03	-0.12	-
Total Common Equity	163.16	136.31	52.48	105.2	158.38	136.41
Shareholders' Equity	163.16	136.31	52.48	105.2	158.38	136.41
Total Liabilities & Equity	173.69	150.83	70.32	132.42	184.24	157.91

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.22	-	0.83	1.27	1.66	0.61
Net Cash (Debt)	169.45	145.7	46.4	107.58	170.9	148.38
Net Cash Growth	4.22%	213.97%	-56.87%	-37.05%	15.17%	-
Net Cash Per Share	2.15	2.35	1.72	4.00	7.59	16.63
Filing Date Shares Outstanding	59.01	47.2	46.78	24.55	24.44	20.93
Total Common Shares Outstanding	59.01	47.15	24.68	24.55	24.44	20.89
Working Capital	161.53	134.49	44.21	98.19	161.19	136
Book Value Per Share	2.76	2.89	2.13	4.28	6.48	6.53
Tangible Book Value	163.16	136.31	52.48	105.2	158.38	132.6
Tangible Book Value Per Share	2.76	2.89	2.13	4.28	6.48	6.35
Machinery	0.38	0.38	0.59	0.55	0.4	0.09
Construction In Progress	0	-	6.59	4.39	0.08	-
Leasehold Improvements	-	-	0.13	0.13	0.13	-

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error